Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress

• Published in: Blood Vol. 142; no. 25; pp. 2159 - 2174
• Main Authors: Melnick, Ashley F., Mullin, Carea, Lin, Karena, McCarter, Anna C., Liang, Shannon, Liu, Yiran E., Wang, Qing, Jerome, Nicole A., Choe, Elizabeth, Kunnath, Nicholas, Bodanapu, Geethika, Akter, Fatema, Magnuson, Brian, Kumar, Surinder, Lombard, David B., Muntean, Andrew G., Ljungman, Mats, Sekiguchi, JoAnn, Ryan, Russell J. H., Chiang, Mark Y.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 21.12.2023; The American Society of Hematology
• Subjects: 5'-Nucleotidase - genetics; 5'-Nucleotidase - metabolism; Animals; Cell Line, Tumor; Chromatin; DNA Damage - genetics; Leukemia, T-Cell - genetics; Leukemia, T-Cell - metabolism; Lymphoid Neoplasia; Mice; Mitochondria - genetics; Mitochondria - metabolism; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - metabolism; Receptor, Notch1 - genetics; Receptor, Notch1 - metabolism; Transcription Factors - genetics
• ISSN: 0006-4971; 1528-0020; 1528-0020
• DOI: 10.1182/blood.2023020144

•Notch might overcome its inherent weakness as a transactivator in T-ALL by cobinding powerful RNA synthesis machinery.•The CDC73-induced DNA repair program co-opted by Notch is more highly expressed in T-ALL than in other tumors and mitigates genotoxic stress. [Display omitted] Activated Notch signaling is highly prevalent in T-cell acute lymphoblastic leukemia (T-ALL), but pan-Notch inhibitors showed excessive toxicity in clinical trials. To find alternative ways to target Notch signals, we investigated cell division cycle 73 (Cdc73), which is a Notch cofactor and key component of the RNA polymerase–associated transcriptional machinery, an emerging target in T-ALL. Although we confirmed previous work that CDC73 interacts with NOTCH1, we also found that the interaction in T-ALL was context-dependent and facilitated by the transcription factor ETS1. Using mouse models, we showed that Cdc73 is important for Notch-induced T-cell development and T-ALL maintenance. Mechanistically, chromatin and nascent gene expression profiling showed that Cdc73 intersects with Ets1 and Notch at chromatin within enhancers to activate expression of known T-ALL oncogenes through its enhancer functions. Cdc73 also intersects with these factors within promoters to activate transcription of genes that are important for DNA repair and oxidative phosphorylation through its gene body functions. Consistently, Cdc73 deletion induced DNA damage and apoptosis and impaired mitochondrial function. The CDC73-induced DNA repair expression program co-opted by NOTCH1 is more highly expressed in T-ALL than in any other cancer. These data suggest that Cdc73 might induce a gene expression program that was eventually intersected and hijacked by oncogenic Notch to augment proliferation and mitigate the genotoxic and metabolic stresses of elevated Notch signaling. Our report supports studying factors such as CDC73 that intersect with Notch to derive a basic scientific understanding on how to combat Notch-dependent cancers without directly targeting the Notch complex.